Paris Soir - Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

NYSE - LSE

RYCEF	0%	20.12	$
VOD	2.23%	17.285	$
RBGPF	0%	70	$
CMSC	0.22%	20.855	$
BTI	0.14%	55.43	$
AZN	-0.71%	161.56	$
RIO	2.14%	105.53	$
GSK	-2.31%	48.765	$
RELX	-2.19%	34.75	$
NGG	-0.09%	78.05	$
BCC	-1.97%	77.68	$
CMSD	-0.1%	20.67	$
BP	2.36%	44.87	$
JRI	0.29%	12.175	$
BCE	-0.4%	23.575	$

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

ECONOMY 08.09.2026

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital" / Photo: © Financewire ( 213582 )

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Text size:

Octrado introduces its proprietary trading, a service that gives traders access to firm capital through a structured evaluation process. Under the model "Your Skill. Our Capital", the platform positions itself between the retail trader and the funded-account system, with the emphasis placed on the operational layer – data environment, rule clarity, evaluation and payouts – rather than on headline account sizes alone.

The programme follows a simple sequence: the trader registers, selects a programme, meets the stated conditions of the challenge, and — on passing — receives funded trader status with a share of the potentital profits generated. The design principle is that a trader must know in advance what is measured, what the limits are, when a rule is considered breached, and what the route from challenge to payout looks like.

Communicated programme parameters

The offering includes:

profit split of up to 90%
account sizes of up to USD 100,000
leverage of up to 1:100
the option to hold positions overnight, subject to programme rules
a restricted weekend trading regime
defined rules for trading around news releases

The offering also includes trading reports, tracking of trade success rate, drawdown and progress, educational materials, and client support. In an environment where selection is demanding, these elements determine whether a challenge is perceived as a fair test or as an opaque filter.

The professionalisation of proprietary trading is not a question of a better interface. It is the ability to maintain a consistent system — the same rules before and after the challenge, clear documentation, auditable reporting, and a legally correct separation of simulation from the live market. Where a platform holds those layers together, its position in the ecosystem rests on an infrastructure of trust rather than on the marketing of funded accounts.

Prop-trading surges in its volume. In its recent study, analysts of Octrado provided a global estimate, which puts the primary prop-trading market, the direct annual revenue of prop firms, at USD 4.0 to 4.5 billion, and the broader ecosystem value, which adds downstream brokerage fees and notionally allocated capital, at around USD 20 billion.

About Octrado

Octrado is a dynamic investment company built on transparency, innovation, and professional trader support. Rather than developing our own proprietary platform, we rely on the globally trusted MetaTrader 5 (MT5) environment, allowing our clients to trade on a stable, proven, and technologically advanced system recognized worldwide.

Octrado LTD. is a limited liability company regulated as a Securities Dealer by the Seychelles Financial Services Authority of Seychelles (“FSA”) with license number SD013 and with company number 8417634-1 to carry out certain categories of financial investment business as permitted under the Seychelles Securities Act 2007.

For more information users can visit: https://octrado.com/en/trading

Risk Warning - This marketing material is provided for informational purposes only and does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any financial instruments.

Trading in securities involves significant risk and may not be suitable for all investors. Prices of securities may fluctuate significantly and may result in a total loss of your investment. Investors should be aware that losses may exceed potential profits when buying and selling securities. In certain market conditions, you may sustain losses that exceed your initial investment. Securities and contracts for differences are complex financial instruments that require a high level of knowledge and understanding. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money.

Contact

Team of analytics
Octrado LTD
[email protected]

Source article: https://financewire.com/2026/09/08/octrado-introduces-its-proprietary-trading-offering-your-skill-our-capital/

L.Lefevre--PS

Featured

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

CapTLX Expands Institutional-Oriented Platform for Access to U.S. Capital Markets

CapTLX, the securities trading and investment platform operated by CHAINLION TECH LTD, today announced the continued expansion of its technology infrastructure for qualified investors and institutional market participants seeking structured access to U.S. equity and private capital markets.

France's Mistral sees value soar with 3 bn euro cash infusion

French AI firm Mistral said Tuesday that it raised three billion euros in what it called the largest-ever European tech fundraising, propelling its overall value to 21 billion euros ($24 billion).